AquaBounty’s Genetically Engineered Salmon Waiting for FDA’s Final Approval
AquaBounty Technologies, the Waltham (Mass.) Company was waiting to get a green flag from the U. S. Food and Drug Administration since past 15 years, to retail a genetically engineered salmon.
The fish grows twice as quickly as its natural counterpart. Last week, the FDA counselors said that a final hearing is pending to decide the fate of AquaBounty's salmon.
The time for the final verdict has not been fixed, but FDA’s personnel have admitted that the modified salmon fish is safe for consumption, with no biological relevant disparities. So, it is likely that AquaBounty's salmon might hit the food markets soon.
It is said that if the fish gets a go-ahead signal from the FDA, it would be the foremost in a sequence of animals with mix-and-match DNA, which will alter the U. S. food chain.
But, it seems that some groups will not be happy if the altered fish reaches the market. On Sept. 16, a demonstration was organized in Washington.
Ben & Jerry's CEO Jostein Solheim told protesters, "Today it's a fish that we're talking about. But very soon it will be genetically engineered pigs, chicken, and our beloved cows".
Atlantic salmon of AquaBounty has a growth gene that has been taken from some other variety of salmon, which is activated by DNA from an eel-like being known as the ocean pout.
United Kingdom News
- British online casino games developer Playtech to make charitable donation worth £3.5 million
- VIP Gamblers remain devoted to gambling hub Macau but fail to bolster gross gaming revenue
- COVID-19 lockdown pushes online casino searches to 'all-time’ high
- UK Betting industry enjoys £1 billion tax rebate
- American Gaming Association urges President Trump to revise tax threshold on slots